Yashaha Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-07-2024
- Paid Up Capital ₹ 1.00 M
as on 08-07-2024
- Company Age 33 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 29.42%
(FY 2022)
- Profit 4.45%
(FY 2022)
- Ebitda -2028.53%
(FY 2022)
- Net Worth 1.23%
(FY 2022)
- Total Assets 1.77%
(FY 2022)
About Yashaha Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Puneet Nagendra, Praba Kanni, Sudha Komarla, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33125KA1991PTC012473
- Company No.
012473
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Yashaha Laboratories Private Limited offer?
Yashaha Laboratories Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Digestive Drugs, Nutraceuticals & Dietary Supplements, Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Cough Syrup, Nutraceuticals.
Who are the key members and board of directors at Yashaha Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannilakshmaniyer Paranjyothi  | Managing Director | 04-Sep-1998 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagendra Venugopal | Director | 06-Nov-1991 | Current |
| Puneet Nagendra | Additional Director | 20-Jun-2019 | Current |
| Praba Kanni | Director | 06-Nov-1991 | Current |
| Sudha Komarla | Director | 04-Sep-1998 | Current |
Financial Performance and Corporate Structure Insights of Yashaha Laboratories.
Yashaha Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.42% increase. The company also saw a slight improvement in profitability, with a 4.45% increase in profit. The company's net worth moved up by a moderate rise of 1.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yashaha Laboratories?
In 2019, Yashaha Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Somerset Therapeutics Private LimitedActive 34 years 4 monthsKannilakshmaniyer Paranjyothi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yashaha Laboratories?
Unlock and access historical data on people associated with Yashaha Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yashaha Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yashaha Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
